Search results
Results From The WOW.Com Content Network
The Dengvaxia controversy (locally [dɛŋˈvakʃa]) occurred in the Philippines when the dengue vaccine Dengvaxia was found to increase the risk of disease severity for some people who had received it. [1] [2] A vaccination program run by the Philippine Department of Health (DOH) administered Sanofi Pasteur's Dengvaxia to schoolchildren. [3]
The Philippines is considering re-introducing a dengue vaccine whose use it halted because of links to the deaths of several children, as authorities battle to contain a dengue outbreak that has ...
The 2017 dengue vaccine controversy in the Philippines involved a vaccination program run by the Philippines Department of Health (DOH). [26] The DOH vaccinated schoolchildren with Sanofi Pasteur's CYD-TDV (Dengvaxia) dengue vaccine. Some of the children who received the vaccine had never been infected by the dengue virus before.
Dengvaxia controversy – involving former president Benigno Aquino III, Health Secretary Janette Garin and Budget and Management Secretary Florencio Abad for the launching of the mass vaccination campaign in 2016, that led to the reports of several children dying from various complications allegedly attributed to the dengue vaccine. [18] 2018 ...
Takeda's vaccine, branded as QDENGA, was authorized in the European Union last year for use in those aged 4 and older to prevent any of the four so-called serotypes of dengue. Takeda withdraws US ...
Takeda's vaccine, given in two doses over a three-month interval, protects against four serotypes of the dengue virus. It was cleared by WHO for use in children aged 6 to 16 in areas with high ...
UNICEF and the WHO has also attributed increase vaccine hesitancy in 2018 due to the Dengue vaccine controversy as a factor contributing to the outbreak. [5] Statistical data from UNICEF, however, shows that decline in Measles vaccination began as early as 2014, four years before the Dengvaxia controversy happened.
South America is seeing a surge in cases of the mosquito-borne disease dengue during the southern hemisphere summer, prompting Brazil to roll out a novel vaccine campaign, while in Argentina many ...